Fox Chase Cancer Center Endowed Chairs

Endowed Chairs Endowed Chairs Home G. Morris Dorrance Jr. Chair in Medical Oncology Gloria and Edmund M. Dunn Chair in Thoracic Surgical Oncology Marvin S. Greenberg, MD Chair in Pancreatic Cancer Surgery Gerald E. Hanks Chair in Radiation Oncology G. Willing "Wing" Pepper Chair in Cancer Research Stanley P. Reimann Chair in Oncology Research Jack Schulz Chair in Basic Science Timothy R. Talbot Jr. Chair in Cancer Research Carol and Kenneth Weg Chair in Human Genetics Robert C. Young MD Chair in Cancer Research Paul Grotzinger and Wilbur Raab Chair in Surgical Oncology Samuel M.V. Hamilton Chair in Prevention Alfred G. Knudson Jr. Chair in Basic Science Donald E. and Shirley C. Morel, Stanley and Stella Bayster Chair in Molecular Imaging Audrey Weg Schaus and Geoffrey Alan Weg Chair in Medical Science H.O. West and J.R. Wike Chair in Cancer Research William Wikoff Smith Chair in Cancer Research Chairholders J. Robert Beck, MD Jeff Boyd, PhD Jonathan Chernoff, MD, PhD Mary B. Daly, MD, PhD, FACP Paul F. Engstrom, MD Eric M. Horwitz, MD John P. Hoffman, MD, FACS Beatrice Mintz, PhD Walter J. Scott, MD, FACS Anna M. Skalka, PhD Joseph R. Testa, PhD Robert G. Uzzo, MD, FACS David S. Weinberg, MD, MSc

Robert C. Young MD Chair
in Cancer Research

This chair was established in 2007 through the generosity of Fox Chase Cancer Center board member Margot Keith and husband Robert Keith, as well as close friends and colleagues, to honor medical oncologist and cancer leader Robert C. Young, MD, an internationally recognized expert in lymphoma and ovarian cancer and Fox Chase’s president from 1988 to 2007.  This chair recognizes and supports an outstanding leader in the field of cancer research who represents the highest standards of excellence.

Jeff Boyd, PhD

Senior Vice President, Molecular Medicine,
Robert C. Young, MD, Chair in Cancer Research,
Executive Director, Cancer Genome Institute,
Chief, Division of Molecular Pathology
Professor, Cancer Biology Program
Dr. Boyd has been the principle architect in the launch of the CGI, developed to explore productive collaborations with government agencies, other academic centers, and biotechnology and pharmaceutical companies. His previous position was Chief Scientific Officer.

Boyd is an international expert in translational research and has particular expertise in the genetics of breast, ovarian and endometrial cancer. He has helped define the role of tumor suppressors and oncogenes in these malignancies, most notably the p53, BRCA1 and BRCA2 tumor suppressor genes and their role in the development of breast and ovarian cancer.

Before coming to Fox Chase in 2008, Boyd was director of the Curtis and Elizabeth Anderson Cancer Institute and vice president of oncology and research at the Memorial University Medical Center in Savannah, Georgia. He also served as the professor of medicine, surgery, obstetrics and gynecology at the Mercer University School of Medicine. At Mercer University, he served as the assistant dean of research. He also holds the title of Distinguished Cancer Scholar from the state of Georgia.

Prior to his roles in Savannah, Boyd served a variety of leadership roles at the Memorial Sloan Kettering Cancer Center in New York. At MSKCC, he was director of the gynecology and breast research laboratory in the department of surgery as well as the director of diagnostic molecular genetics laboratory within the department of medicine. Before serving at MSKCC, he had faculty positions at the University of Pennsylvania, the University of North Carolina, and the National Institutes of Health (NIH).